BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kalender ME, Sevinc A, Tutar E, Sirikci A, Camci C. Effect of sunitinib on metastatic gastrointestinal stromal tumor in patients with neurofibromatosis type 1: A case report. World J Gastroenterol 2007; 13(18): 2629-2632 [PMID: 17552016 DOI: 10.3748/wjg.v13.i18.2629]
URL: https://www.wjgnet.com/1007-9327/full/v13/i18/2629.htm
Number Citing Articles
1
Angela C Hirbe, David H Gutmann. Neurofibromatosis type 1: a multidisciplinary approach to careThe Lancet Neurology 2014; 13(8): 834 doi: 10.1016/S1474-4422(14)70063-8
2
Emma Burkitt Wright, Michael Burkitt, Hilde Brems. Multidisciplinary Approach to Neurofibromatosis Type 12020; : 101 doi: 10.1007/978-3-319-92450-2_8
3
Judit Bajor. Gastrointestinal stromal tumors in neurofibromatosis type 1Orvosi Hetilap 2009; 150(4): 149 doi: 10.1556/oh.2009.28478
4
Ke Xiao, Xin‐Yu Tan, Hui‐Huan Tang, Shi Chang, Jun Zhou, Xue‐Jun Gong. Gastrointestinal stromal tumours in patients with neurofibromatosis type 1: A case report and retrospective review of 72 casesSurgical Practice 2013; 17(3): 115 doi: 10.1111/j.1744-1633.2012.00621.x
5
Jinchun Wu, Haiyan Zhou, Xiaoping Yi, Qiongzhi He, Tianxiang Lei, Fengbo Tan, Heli Liu, Bin Li. Targeted Deep Sequencing Reveals Unrecognized KIT Mutation Coexistent with NF1 Deficiency in GISTsCancer Management and Research 2021; : 297 doi: 10.2147/CMAR.S280174
6
Ursula Basile, Giuseppe Cavallaro, Andrea Polistena, Sandra Giustini, Gennaro Orlando, Dario Cotesta, Luigi Petramala, Claudio Letizia, Stefano Calvieri, Giorgio De Toma. Gastrointestinal and Retroperitoneal Manifestations of Type 1 NeurofibromatosisJournal of Gastrointestinal Surgery 2010; 14(1): 186 doi: 10.1007/s11605-009-0940-5
7
Rinki Agarwal, Mark Robson. Inherited Predisposition to Gastrointestinal Stromal TumorHematology/Oncology Clinics of North America 2009; 23(1): 1 doi: 10.1016/j.hoc.2008.12.003
8
Christina Bergqvist, Amandine Servy, Laurence Valeyrie-Allanore, Salah Ferkal, Patrick Combemale, Pierre Wolkenstein. Neurofibromatosis 1 French national guidelines based on an extensive literature review since 1966Orphanet Journal of Rare Diseases 2020; 15(1) doi: 10.1186/s13023-020-1310-3
9
Haixin Zhang, Qi Liu. Prognostic Indicators for Gastrointestinal Stromal Tumors: A ReviewTranslational Oncology 2020; 13(10): 100812 doi: 10.1016/j.tranon.2020.100812
10
Adriana Ziółkowska, Katarzyna Glińska, Sylwia Szymańska, Sergiusz Jóźwiak. Nerwiakowłókniakowatość typu 1 – choroba wymagająca wielodyscyplinarnej opieki specjalistycznejPediatria Polska 2017; 92(3): 294 doi: 10.1016/j.pepo.2016.12.005
11
Subotheni Thavaneswaran, Emma Rath, Kathy Tucker, Anthony M. Joshua, Dominique Hess, Mark Pinese, Mandy L. Ballinger, David M. Thomas. Therapeutic implications of germline genetic findings in cancerNature Reviews Clinical Oncology 2019; 16(6): 386 doi: 10.1038/s41571-019-0179-3
12
Judit Bajor. Gastrointestinal stromal tumours in patients with type 1 neurofibromatosisClinical and Experimental Medical Journal 2009; 3(2): 247 doi: 10.1556/CEMED.3.2009.28478
13
Katherine A. Janeway. Gastrointestinal Stromal Tumors2017; : 45 doi: 10.1007/978-3-319-42632-7_4
14
Alper Sevinc, Celalettin Camci, Mustafa Yilmaz, Hakan Buyukhatipoglu. The Diagnosis of C-Kit Negative GIST by PDGFRA Staining: Clinical, Pathological, and Nuclear Medicine PerspectiveOncology Research and Treatment 2007; 30(12): 645 doi: 10.1159/000109978
15
Priya Gopie, Lin Mei, Anthony C Faber, Steven R Grossman, Steven C Smith, Sosipatros A Boikos. Classification of gastrointestinal stromal tumor syndromesEndocrine-Related Cancer 2018; 25(2): R49 doi: 10.1530/ERC-17-0329
16
Michael A Postow, Mark E Robson. Inherited gastrointestinal stromal tumor syndromes: mutations, clinical features, and therapeutic implicationsClinical Sarcoma Research 2012; 2(1) doi: 10.1186/2045-3329-2-16
17
Chiara Mussi, Hans-Ulrich Schildhaus, Alessandro Gronchi, Eva Wardelmann, Peter Hohenberger. Therapeutic Consequences from Molecular Biology for Gastrointestinal Stromal Tumor Patients Affected by Neurofibromatosis Type 1Clinical Cancer Research 2008; 14(14): 4550 doi: 10.1158/1078-0432.CCR-08-0086
18
Alka Mittal, Daniel Felter, S. Michelle Shiller, A. David Mccollum, Jeffrey P. Lamont, Damien Mallat. Gastrointestinal Bleeding and Cutaneous NodulesBaylor University Medical Center Proceedings 2008; 21(3): 331 doi: 10.1080/08998280.2008.11928420
19
Giuseppe Cavallaro, Ursula Basile, Andrea Polistena, Sandra Giustini, Rossella Arena, Alessandro Scorsi, Laura Zinnamosca, Claudio Letizia, Stefano Calvieri, Giorgio De Toma. Surgical Management of Abdominal Manifestations of Type 1 Neurofibromatosis: Experience of a Single CenterThe American Surgeon™ 2010; 76(4): 389 doi: 10.1177/000313481007600416
20
Sachin Patil, Ronald S. Chamberlain. Neoplasms Associated with Germline and Somatic NF1 Gene MutationsThe Oncologist 2012; 17(1): 101 doi: 10.1634/theoncologist.2010-0181
21
Daniel Relles, Jennie Baek, Agnieszka Witkiewicz, Charles J. Yeo. Periampullary and Duodenal Neoplasms in Neurofibromatosis Type 1: Two Cases and an Updated 20-Year Review of the Literature Yielding 76 CasesJournal of Gastrointestinal Surgery 2010; 14(6): 1052 doi: 10.1007/s11605-009-1123-0
22
Annarosaria De Chiara, Angelo Paolo Dei Tos. GISTs — Gastrointestinal Stromal Tumors2011; : 3 doi: 10.1007/978-88-470-1869-3_1
23
S. Charfi, I. Gargouri, R. Kallel, H. Abid, H. Mnif, T. Sellami-Boudawara. Association of multiple gastrointestinal stromal tumor (GIST) and gastric schwannoma in a patient with type 1 neurofibromatosisJournal Africain d'Hépato-Gastroentérologie 2015; 9(2): 60 doi: 10.1007/s12157-015-0586-8